Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Imran Satia

Showing results (81-90 of 105) with videos related to

Pageof 11
Sort By:
Chest|May 15, 2026
Moving Beyond Responders: A post-hoc Analysis Identifying Criteria for Chronic Cough ControlMustafaa Wahab, Elena Kum, Nermin Diab, et al.
Lung|February 22, 2023
Canadian Health Care Professionals' Familiarity with Chronic Cough Guidelines and Experiences with Diagnosis and Management: A Cross-Sectional SurveyElena Kum, Danica Brister, Nermin Diab, et al.
ERJ Open Research|March 17, 2018
Research highlights from the 2017 ERS International Congress: airway diseases in focusCecilia Andersson, Sara J Bonvini, Peter Horvath, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 15, 2022
Demographic, clinical, and patient-reported outcome data from 2 global, phase 3 trials of chronic coughPeter V Dicpinigaitis, Surinder S Birring, Michael Blaiss, et al.
Lung|July 27, 2022
Improvements in Objective and Subjective Measures of Chronic Cough with Gefapixant: A Pooled Phase 3 Efficacy Analysis of Predefined SubgroupsJaclyn A Smith, Surinder S Birring, Peter V Dicpinigaitis, et al.
The European Respiratory Journal|November 6, 2025
Mepolizumab for the treatment of refractory chronic cough in patients with eosinophilic airways disease (MUCOSA): a randomized, double-blind, parallel-group, placebo-controlled trialNermin Diab, Danica Brister, Elena Kum, et al.
The European Respiratory Journal|May 7, 2026
Reply to: Is the role of eosinophils in refractory chronic cough truly dismissed? Mepolizumab reduced blood and sputum eosinophils, but not eosinophil-derived neurotoxinChristiane Whetstone, Nermin Diab, Danica Brister, et al.
Allergy|June 26, 2023
Protein expression of SARS-CoV-2 receptors ACE2 and TMPRSS2 in allergic airways after allergen challengeChristiane E Whetstone, Maral Ranjbar, Ruth P Cusack, et al.
Allergy|May 10, 2024
Comparison of upper and lower airway expression of SARS-CoV-2 receptors in allergic asthmaMaral Ranjbar, Christiane E Whetstone, Ruth P Cusack, et al.
ERJ Open Research|March 17, 2022
A double-blind randomised placebo-controlled trial investigating the effects of lesogaberan on the objective cough frequency and capsaicin-evoked coughs in patients with refractory chronic coughHuda Badri, Carmen Gibbard, Dimitra Denton, et al.
Pageof 11

Showing results (81-90 of 105) with videos related to

Sort By:
Pageof 11
Chest|May 15, 2026
Moving Beyond Responders: A post-hoc Analysis Identifying Criteria for Chronic Cough ControlMustafaa Wahab, Elena Kum, Nermin Diab, et al.
Lung|February 22, 2023
Canadian Health Care Professionals' Familiarity with Chronic Cough Guidelines and Experiences with Diagnosis and Management: A Cross-Sectional SurveyElena Kum, Danica Brister, Nermin Diab, et al.
ERJ Open Research|March 17, 2018
Research highlights from the 2017 ERS International Congress: airway diseases in focusCecilia Andersson, Sara J Bonvini, Peter Horvath, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 15, 2022
Demographic, clinical, and patient-reported outcome data from 2 global, phase 3 trials of chronic coughPeter V Dicpinigaitis, Surinder S Birring, Michael Blaiss, et al.
Lung|July 27, 2022
Improvements in Objective and Subjective Measures of Chronic Cough with Gefapixant: A Pooled Phase 3 Efficacy Analysis of Predefined SubgroupsJaclyn A Smith, Surinder S Birring, Peter V Dicpinigaitis, et al.
The European Respiratory Journal|November 6, 2025
Mepolizumab for the treatment of refractory chronic cough in patients with eosinophilic airways disease (MUCOSA): a randomized, double-blind, parallel-group, placebo-controlled trialNermin Diab, Danica Brister, Elena Kum, et al.
The European Respiratory Journal|May 7, 2026
Reply to: Is the role of eosinophils in refractory chronic cough truly dismissed? Mepolizumab reduced blood and sputum eosinophils, but not eosinophil-derived neurotoxinChristiane Whetstone, Nermin Diab, Danica Brister, et al.
Allergy|June 26, 2023
Protein expression of SARS-CoV-2 receptors ACE2 and TMPRSS2 in allergic airways after allergen challengeChristiane E Whetstone, Maral Ranjbar, Ruth P Cusack, et al.
Allergy|May 10, 2024
Comparison of upper and lower airway expression of SARS-CoV-2 receptors in allergic asthmaMaral Ranjbar, Christiane E Whetstone, Ruth P Cusack, et al.
ERJ Open Research|March 17, 2022
A double-blind randomised placebo-controlled trial investigating the effects of lesogaberan on the objective cough frequency and capsaicin-evoked coughs in patients with refractory chronic coughHuda Badri, Carmen Gibbard, Dimitra Denton, et al.
Pageof 11